Thermo Fisher Scientific (US), Agilent Technologies (US), And AB SCIEX (US) are the Major Players Operating in the Biomarker Technologies Market for Mass Spectrometry and Chromatography.
The global biomarker technologies market is expected to reach USD 74.51 Billion in 2022 from USD 46.97 Billion in 2017, at a CAGR of 9.7% during the forecast period.
While organic strategies remain central to the business growth initiatives pursued by the majority of key players in the biomarker technologies market for mass spectrometry and chromatography, agreements, expansion, and acquisition have also emerged as prominent means of increasing company presence in high-growth markets.
Thermo Fisher offers a wide range of products in the biomarker technologies market for mass spectrometry and chromatography, including GC, LC, GC-MS, LC-MS, NMR spectrometers, and bioinformatics tools for metabolite analysis. The company has a strong presence in the US. The company focuses on acquisition, collaboration, and product innovation to increase its portfolio for MS and chromatography. In 2016, Thermo Fisher entered into collaboration with the National Institute for Bioprocessing Research and Training (NIBRT), Ireland. NIBRT employed Thermo Fisher’s Orbitrap high-resolution mass spectrometers for the characterization of complex biopharmaceuticals.
Agilent Technologies has maintained its leadership in the market through its strong distribution networks across North America, Europe, and Asia Pacific. Through R&D investments, the company continues to introduce innovative and differentiated products in the market. The company focuses on product launches, agreements, co-marketing strategies, and collaboration to expand its business operations and increase its market share. For instance, in 2017, the company launched a series of LC/MS systems in this market, including Agilent Ultivo Triple Quadrupole LC/MS, Agilent InfinityLab Series LC/MSD Single Quadrupole LC/MS, Agilent AdvanceBio 6545XT LC/Q-TOF LC/MS, 6495B Triple Quadrupole LC/MS System, and Agilent 7250 GC/Q-TOF System.
Danaher Corporation operates in the market through its subsidiary, AB SCIEX. AB SCIEX manufactures and markets MS systems and software for drug discovery research. Danaher has a strong presence in over 50 countries across the globe through its R&D, manufacturing, sales, distribution, services, and administrative facilities. In 2017, AB SCIEX introduced the Topaz LC-MS/MS System in this market.
Other leading players in the biomarker technologies market for MS and chromatography include Waters Corporation (US), Shimadzu Corporation (Japan), Bio-Rad Laboratories (US), Restek Corporation (US), Gilson, Inc. (US), JASCO, Inc. (US), SCION Instruments (US), and Perkin Elmer, Inc. (US). These companies focus on investing in R&D activities to add innovative technologies and products to their portfolio. With a strong portfolio of MS and chromatography products and ceaseless efforts to develop innovative products, these companies are likely to maintain their strong position in the market in the coming years.
Related Reports:
Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy (ddPCR, DHPLC)), Research Area (Proteomics, Lipidomics), Application (Biomarker Validation, Biomarker Discovery) - Global Forecast to 2022
Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
